NeuBase Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Equipment

12 Months Ended

Sep. 30, 2021

5. Equipment

The Company’s equipment consisted of the following:


	As of September 30,		As of September 30,		Estimated Useful life
	2021		2020		(in years)
Laboratory equipment	$	2,737,390	$	1,319,123	5
Office equipment		259,978		6,477	3
Total		2,997,368		1,325,600
Accumulated depreciation		(533,486)		(158,666)
Property, plant and equipment, net	$	2,463,882	$	1,166,934

Depreciation expense for the years ended September 30, 2021 and 2020 was approximately $0.4 million and $0.1 million, respectively.